With a focus on shared decision making between doctors and patients, more studies needed to determine how decision aids help guide choices for cancer screening.
Study finds gaps in 'decision aids' designed to help determine right cancer screening option for patients
With a focus on shared decision making between doctors and patients, more studies needed to determine how decision aids help guide choices for cancer screeningWritten by: Beata Mostafavi. Media Inquiries: 734-764-2220, 8 a.m.-5 p.m.
Written by: Laurel Thomas Gnagey. Media Inquiries: 734-647-1841, 8 a.m.-5 p.m. ET or firstname.lastname@example.org
Author, educator and grief counselor Alan Wolfelt, Ph.D. will help health professionals in the community better understand methods to address patient and co-worker grief at an address at the University of Michigan May 23, 2013.
Cardiologists and oncologists will work together to prevent heart damage caused by cancer treatment a risk faced by as much as one-third of cancer patientsWritten by: Shantell Kirkendoll. Media Inquiries: 734-764-2220 8 a.m.-5 p.m. ET
University of Michigan Comprehensive Cancer Center experts will discuss breast cancer risks (and how you can reduce yours), as well as screening, treatment and research at a free Breast Cancer Summit on Saturday, April 20, 2013 at Washtenaw Community College.
One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to University of Michigan Comprehensive Cancer Center researchers.
Large, international trial finds intermittent androgen deprivation is not equivalent to continuous treatment of prostate cancer.
New study from the University of Michigan Comprehensive Cancer Center finds Duloxetine reduced painful neuropathy in majority of patients.
New study from the University of Michigan Comprehensive Cancer Center adds prostate to cancers associated with Lynch syndrome.